MetaADEDB 2.0 @ LMMD
Oxyphenbutazone
(HFHZKZSRXITVMK-UHFFFAOYSA-N)
Structure
SMILES
CCCCC1C(=O)N(N(C1=O)c1ccc(cc1)O)c1ccccc1
Type(s)
Approved; Withdrawn
ATC code(s)
M01AA03; M02AA04; S01BC02
Molecular Formula:
C19H20N2O3
Molecular Weight:
324.374
Log P:
3.6234
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
60.85
CAS Number(s):
129-20-4
Synonym(s)
1.
Oxyphenbutazone
2.
Hydroxyphenylbutazone
3.
Diflamil
4.
Oxyphenylbutazone
5.
Tanderil
External Link(s)
MeSHD010113
PubChem Compound4641
BindingDB200298
ChEBI76258
CHEMBLCHEMBL1228
DrugBankDB03585
DrugCentral2036
KEGGcpd:C19494
dr:D08324
Therapeutic Target DatabaseD06ZPS
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 1Canada Vigilance
2AgranulocytosisCanada Vigilance: 23747087CTD
Canada Vigilance
3AmblyopiaCanada Vigilance: 1Canada Vigilance
4AstheniaCanada Vigilance: 1Canada Vigilance
5BlepharitisCanada Vigilance: 1Canada Vigilance
6ChillsCanada Vigilance: 1Canada Vigilance
7DermatitisCanada Vigilance: 4Canada Vigilance
8DizzinessCanada Vigilance: 1Canada Vigilance
9EpistaxisCanada Vigilance: 2Canada Vigilance
10Erythema MultiformeCanada Vigilance: 1Canada Vigilance
11ErythemaCanada Vigilance: 4Canada Vigilance
12Eye irritationCanada Vigilance: 1Canada Vigilance
13Gastritis2266080CTD
14Gingival Hemorrhage5079767CTD
15GingivitisCanada Vigilance: 1Canada Vigilance
16GlomerulonephritisCanada Vigilance: 1Canada Vigilance
17GlossitisCanada Vigilance: 1Canada Vigilance
18HeadacheCanada Vigilance: 1Canada Vigilance
19HepatitisCanada Vigilance: 2Canada Vigilance
20HypersensitivityCanada Vigilance: 5Canada Vigilance
21HyperthyroidismCanada Vigilance: 1Canada Vigilance
22Kidney Cortex Necrosis972771CTD
23LeukopeniaCanada Vigilance: 1Canada Vigilance
24LymphadenopathyCanada Vigilance: 1Canada Vigilance
25MalaiseCanada Vigilance: 3Canada Vigilance
26MyalgiaCanada Vigilance: 1Canada Vigilance
27MydriasisCanada Vigilance: 1Canada Vigilance
28MyocarditisCanada Vigilance: 1Canada Vigilance
29NauseaCanada Vigilance: 2Canada Vigilance
30PainCanada Vigilance: 1Canada Vigilance
31Pancreatitis3832725
10484002
CTD
32PancytopeniaCanada Vigilance: 1Canada Vigilance
33PetechiaeCanada Vigilance: 1Canada Vigilance
34ProteinuriaCanada Vigilance: 1Canada Vigilance
35PruritusCanada Vigilance: 6Canada Vigilance
36PurpuraCanada Vigilance: 25079767CTD
Canada Vigilance
37Rash erythematousCanada Vigilance: 1Canada Vigilance
38SepsisCanada Vigilance: 1Canada Vigilance
39Serum SicknessCanada Vigilance: 1Canada Vigilance
40Sialadenitis3832725CTD
41Skin reactionCanada Vigilance: 1Canada Vigilance
42Stevens-Johnson SyndromeCanada Vigilance: 3Canada Vigilance
43StomatitisCanada Vigilance: 5Canada Vigilance
44SwellingCanada Vigilance: 1Canada Vigilance
45ThrombocytopeniaCanada Vigilance: 3Canada Vigilance
46Thrombocytopenic purpuraCanada Vigilance: 1Canada Vigilance
47UrticariaCanada Vigilance: 6Canada Vigilance
48VertigoCanada Vigilance: 1Canada Vigilance
49VomitingCanada Vigilance: 6Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.